Baba, an applied AI company focused on modernizing Medicare and Medicaid care, has raised $40 million in a Series A funding round led by FirstMark Capital, with participation from CVS Health Ventures and others. The funding will help Baba expand its clinical care teams, advance AI research, and grow partnerships with health plans. Baba supports Medicare patients by coordinating complex care through dedicated teams and AI, aiming to reduce costs and improve patient outcomes. The company has already helped over 10,000 patients and plans to scale further, including collaborations with national health plans and government agencies.
Baba's recent $40 million funding round highlights growing interest in healthcare innovation, which is reflected in CVS Health Corp's steady performance. On Pluang, CVS shares trade at USD 93.97, up 1.39% as of Oct 20, 2026 21:13 WIB, with a market cap of $118.53 billion. Investor activity leans towards buying, with 65% of orders on Pluang being buys and a dividend yield of 2.87%.
